NuFund Venture Group

Resolute Science is a biotechnology company focused on developing innovative medicines for aggressive and hard-to-treat solid tumors. It employs a proprietary technology platform, MAC-TACs (Macrophage Targeted Conjugates), to create a new class of biomarker-driven, first-in-class synthetic molecules. These molecules target tumor-associated macrophages, potentially enhancing efficacy and safety compared to current treatments. Resolute aims to cure a wide range of solid tumors, offering hope to patients with challenging conditions.

Alt Sports Data specializes in providing proprietary data and odds for the gaming and wagering sectors, focusing on emerging and non-mainstream sports. The company acts as a vital link between alternative sports and the gaming industry, offering comprehensive access to sports trading and customer data. By leveraging specialist-managed trading systems, Alt Sports Data enables its clients, including sports leagues, technology platforms, and regulated sportsbooks, to engage with a variety of top-line, derivative, and propositional markets. This approach aims to enhance the market experience and expand audience reach within the sports ecosystem.

Vasa Therapeutics is a privately held biopharmaceutical company based in Encinitas, California, focused on developing therapies for vascular diseases. The company specializes in the discovery and development of treatments for conditions such as heart failure, peripheral artery disease, and sarcopenia. Vasa Therapeutics utilizes an in-house drug discovery testing funnel to identify promising small molecule and peptide therapeutics, aiming to provide healthcare professionals with effective options for managing these significant health issues.

Kneevoice is a company that focuses on maintaining knee health and wellness through its innovative digital patellofemoral audio-arthrography system. Founded in 2015 and based in Santa Monica, California, Kneevoice combines advanced sound acquisition technology with cloud-based machine-learning algorithms. This integration allows for prompt and accurate diagnostics that were previously only achievable through non-dynamic, non-specific, or invasive testing methods. The company's wearable devices empower patients to monitor their knee health effectively, enhancing the overall management of their well-being.

PrivacyHawk is a consumer privacy platform that enables individuals to manage their personal data effectively. The platform automates the processes of opting out, unsubscribing, and deleting private information from various databases that may be misusing clients' data. By helping users reduce their digital footprint, PrivacyHawk enhances their privacy and security, thereby lowering the risks associated with scams, spam, and identity theft. Its services empower clients to take control of their personal information and safeguard their privacy in an increasingly data-driven world.

Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

Duo Oncology is focused on developing innovative nanoparticle technology designed to effectively penetrate established tumors, particularly in challenging cases such as pancreatic and bile duct cancers. The company aims to transform treatment outcomes through a novel monotherapy that enhances patient care for those with hard-to-treat tumors and relapsed metastatic disease. By collaborating with leading university scientists and medical oncologists, Duo Oncology leverages a network of established research organizations to expedite the development of its products. The technology addresses significant needs in immunotherapy and precision medicine, ultimately striving to improve recovery times and patient outcomes.

KeepWOL is a developer of a talent development platform aimed at enhancing team collaboration and fostering inclusion across remote, hybrid, and in-person environments. The platform combines human insights, data, and artificial intelligence to deliver real-time feedback and actionable recommendations, helping organizations identify critical areas for improvement in team dynamics. KeepWOL offers a comprehensive library of content, facilitation training, and ongoing support, all designed to cultivate employee engagement and facilitate cultural transformation. By providing guided immersive experiences, the platform enables companies to develop their workforce effectively while measuring the impact of their initiatives on team effectiveness and organizational health.